Shareholders Request Equitable Access To Medicines
Despite opposition from board and management, beginning this week, eleven proposals pressing for governance changes to increase health equity will go to a shareholder vote at top pharma companies. Shareholders Demand Equitable Access To MedicinesNEW YORK, NY, MONDAY, APRIL 24, 2023 – Shareholders today announced their slate of eleven proposals for 2023 pharma proxies on the use of patents, pharma lobbying, and pricing and access strategies for COVID-19 medicines have successfully made it onto the 2023 proxies of eight pharmaceutical companies. In nearly all cases, board and management opposed ...